Buy Moleculin Biotech Stock | MBRX Stock Price & Latest News | Public
MBRX

Moleculin Biotech

$0.00 (0.00%)Today
    Small Market Cap

    About MBRX

    Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small mol...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.11
    -0.17
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.10

    Actual EPS
    Q4 2020

    Stats

    Market Cap$47,56M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.97
    1 Year Low$0.32
    Open$0.76
    High$0.77
    Low$0.75

    Buy any stock with any amount of money.

    Download the App
    Download the app